Скачать или смотреть Dual GLP-1/GIP Agonist | Tirzepatide | Obesity & T2DM Mx | Harrison's Update(22nd Ed.) | © Dr. Mohan

🚀 Breakthrough in Diabetes & Obesity Treatment!
Discover the science behind Dual GIP and GLP-1 Receptor Agonists—a revolutionary class of medications changing the future of metabolic health. 💉✨

✴️ In this video, we explore Tirzepatide (Mounjaro/Zepbound), the world’s first dual agonist, and how it's transforming lives through powerful effects on blood sugar control and weight loss. ⚖️🔬

💡What you'll learn:
✅ How Tirzepatide works: dual incretin action explained
✅ Dramatic results from clinical trials 📉💪
✅ Real benefits in weight loss & HbA1c reduction
✅ Safety profile & side effects ⚠️
✅ How it compares to other treatments
✅ The future of metabolic therapy 🔮

♦Why watch?
This is not just another diabetes drug—it's a game-changer for people battling Type 2 diabetes and obesity. Whether you're a healthcare professional or someone seeking real solutions, this video delivers powerful insights in a clear, humanized way. 💡❤️

📌 Don’t miss the future of medicine—it starts now.
🔺Subscribe for more videos on cutting-edge health innovations. 🔔

#Tirzepatide #Mounjaro #Zepbound #GLP1 #GIP #Type2Diabetes #ObesityTreatment #WeightLossJourney #DiabetesCare #MetabolicHealth #MedicalBreakthrough